How Fair Is the Standard of Care?
If every patient is unique, can an overarching metric really be pinned down enough to declare that a given doctor was negligent as a legal certainty?
Read More
Yescarta – Oncology – Gilead- Yescarta Dec Display Banners HCP Wallboard Extension – 54899
Valid Biomarker Predicts Local Regrowth and Distant Metastasis in Rectal Cancer
For patients with rectal cancer, no biomarker capable of improving monitoring and selection exists for those managed with a watch-and-wait (W&W) strategy, notes Franck Pagès, MD, PhD. Following neoadjuvant chemoradiotherapy,...
Read More
Prevalence of Hearing Loss Significantly Higher for Cancer Survivors
Cancer survivors have a significantly higher prevalence of hearing loss (HL) than the general...
Read More
NCCN: Cancer Centers Still Experiencing Shortages of Chemo Drugs
Many cancer centers are still experiencing a shortage of carboplatin, cisplatin, and other...
Read More
Shorter Courses of Radiotherapy Increasingly Used for Prostate Cancer
From 2004 to 2020, there was an increase in the use of shorter radiotherapy (RT) courses...
Read More
Multicancer Early Detection Blood Tests Are Feasible
Multicancer early detection (MCED) blood tests are feasible for detecting cancer, according to a...
Read More